MedPath

A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain

Phase 1
Completed
Conditions
Diabetes Mellitus
Registration Number
NCT01937702
Lead Sponsor
Profil Institut für Stoffwechselforschung GmbH
Brief Summary

A trial, investigating the influence of injection speed and volume on the perception of subcutaneous injection pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Subject has signed the informed consent form prior to screening
  • Age 18-74 years at screening (both included)
Exclusion Criteria
  • Known or suspected hypersensitivity to needle, ink ball pen or other that are in contact with the injection area during the clinical visit
  • Previous participation in this trial. Participation is defined as having received at least one injection

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
injection painwithin 24 hours after injection
Secondary Outcome Measures
NameTimeMethod
variability of injection painwithin the first 24 hours after injection

Trial Locations

Locations (1)

Profil Mainz GmbH & Co. KG

🇩🇪

Mainz, Rheinland-Pfalz, Germany

Profil Mainz GmbH & Co. KG
🇩🇪Mainz, Rheinland-Pfalz, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.